CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome

Journal of Investigative Dermatology

Volumn 128, Issue 2, 2008, Pages 465-472

  Ortonne, Nicolas ^a,b,c   Le Gouvello, Sabine ^a,b,c   Mansour, Hicham ^a   Poillet, Catherine ^a   Martin, Nadine ^a,c   Delfau Larue, Marie Hélène ^a,c   Leroy, Karen ^a,c   Farcet, Jean Pierre ^a,c   Bagot, Martine ^a,b,c   Bensussan, Armand ^b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; MESSENGER RNA; MONOMER; PROTEIN CD 158 K; PROTEIN KIR 3 DL 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHRODERMA; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEZARY SYNDROME; SKIN CULTURE; SKIN DEFECT;

EID: 38149120371     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701013     Document Type: Article

References (44)

1. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H (2005) Erythroderma: a clinical study of 97 cases. BMC Dermatol 5:5
2. Assaf C, Hummel M, Zemlin M, Steinhoff M, Geilen CC, Stein H et al. (2004) Transition of Sezary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis. J Clin Pathol 57:1325-8
3. Bagot M, Moretta A, Sivori S, Biassoni R, Cantoni C, Bottino C et al. (2001) CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 97:1388-91
4. Bagot M, Wechsler J, Lescs MC, Revuz J, Farcet JP, Gaulard P (1992) Intraepidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:589-93
5. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P et al. (2001) The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 144:125-35
6. Curco N, Servitje O, Llucia M, Bertran J, Limon A, Carmona M et al. (1997) Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene. Br J Dermatol 137:673-9
7. Delfau-Larue MH, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M et al. (2000) Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 96:2987-92
8. Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6:995-1001
9. Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L et al. (1995) Expression of V beta gene segments by Sezary cells. J Invest Dermatol 105:56-61
10. Guitart J, Kaul K (1999) A new polymerase chain reaction-based method for the detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch Dermatol 135:158-62
11. Huet D, Bagot M, Loyaux D, Capdevielle J, Conraux L, Ferrara P et al. (2006) SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J Immunol 176:652-9
12. Jones D, Dang NH, Duvic M, Washington LT, Huh YO (2001) Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115:885-92
13. Ju J, Pedersen-Lane J, Maley F, Chu E (1999) Regulation of p53 expression by thymidylate synthase. Proc Natl Acad Sci USA 96:3769-74
14. Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M et al. (2005) Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 65:8101-10
15. Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C et al. (2003) Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 197:1477-88
16. Lin CS, Park T, Chen ZP, Leavitt J (1993) Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. J Biol Chem 268:2781-92
17. Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC et al. (2004) BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 151:546-56
18. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ (2003) Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101:1513-9
19. Marie-Cardine A, Huet D, Ortonne N, Remtoula N, Le Gouvello S, Bagot M et al. (2007) Killer cell Ig-like receptors CD158a and CD158b display a co-activatory function, involving the c-jun NH2-terminal protein kinase signaling pathway, when both expressed on malignant CD4+ T cells from a Sezary patient. Blood 109:5064-5
20. Mesel-Lemoine M, Cherai M, Le Gouvello S, Guillot M, Leclercq V, Klatzmann D et al. (2006) Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy. Blood 107:381-8
21. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A et al. (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155:105-17
22. Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, Lessin S et al. (2006) Quantitative PCR on 5 genes reliably identifies CTCL patients with 5-99% circulating tumor cells with 90% accuracy. Blood 107:3189-96
23. Ortonne N, Buyukbabani N, Delfau-Larue MH, Bagot M, Wechsler J (2003) Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides. Mod Pathol 16:857-62
24. Ortonne N, Huet D, Gaudez C, Marie-Cardine A, Schiavon V, Bagot M et al. (2006) Significance of circulating T-cell clones in Sezary syndrome. Blood 107:4030-8
25. Pal S, Haroon TS (1998) Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol 37:104-7
26. Parolini S, Cantoni C, Castriconi R (2002) The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles. Leukocyte Typing VII In: (Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E et al., eds) Oxford: Oxford University Press, 415-7
27. Poszepczynska E, Bagot M, Echchakir H, Martinvalet D, Ramez M, Charue D et al. (2000) Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+) Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 96:1056-63
28. Poszepczynska-Guigne E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N et al. (2004) CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol 122:820-3
29. Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S et al. (2001) CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome. J Am Acad Dermatol 44:456-61
30. Russell-Jones R (2005) Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 153:1-5
31. Rym BM, Mourad M, Bechir Z, Dalenda E, Faika C, Iadh AM et al. (2005) Erythroderma in adults: a report of 80 cases. Int J Dermatol 44:731-5
32. Scala E, Narducci MG, Amerio P, Baliva G, Simoni R, Giovannetti A et al. (2002) T cell receptor-Vbeta analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sezary syndrome patients. J Invest Dermatol 119:193-6
33. Su MW, Dorocicz I, Dragowska WH, Ho V, Li G, Voss N et al. (2003) Aberrant expression of T-plastin in Sezary cells. Cancer Res 63:7122-7
34. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard PS (2004) Statistical modeling for selecting housekeeper genes. Genome Biol 5:R59
35. Tanackovic G, Kramer A (2005) Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo. Mol Biol Cell 16:1366-77
36. Theodorou I, Delfau-Larue MH, Bigorgne C, Lahet C, Cochet G, Bagot M et al. (1995) Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood 86:305-10
37. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B et al. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753-63
38. van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R et al. (2004) Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 64:5578-86
39. Vely F, Peyrat M, Couedel C, Morcet J, Halary F, Davodeau F et al. (2001) Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J Immunol 166:2487-94
40. Vonderheid EC, Sobel EL, Nowell PC, Finan JB, Helfrich MK, Whipple DS (1985) Diagnostic and prognostic significance of Sezary cells in peripheral blood smears from patients with cutaneous T cell lymphoma. Blood 66:358-66
41. Wechsler J, Bagot M, Nikolova M, Parolini S, Martin-Garcia N, Boumsell L et al. (2003) Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes. J Pathol 199:77-83
42. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-85
43. Witzens M, Mohler T, Willhauck M, Scheibenbogen C, Lee KH, Keilholz U (1997) Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis. Ann Hematol 74:123-30
44. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R et al. (1994) Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103:34-41